There’s No One Worse Than Trump on Climate and War
On two issues alone, the 2020 election could be a matter of life and death for millions of people.
Voices
Perspectives on the news from Intercept columnists, reporters, and freelance contributors.
Remote Voting in Congress Isn't Just a Matter of Public Health — It's Necessary for Democrats to Wield Power
Nancy Pelosi has dragged her feet on remote voting to shore up her own influence, but she’s ended up handing over substantial control to Republicans.
The Pandemic Brings Out the Authoritarian and the Libertarian in Us All. Can We Meet in the Middle?
It’s a powerful American ambivalence: on one hand, a punitive instinct; on the other, leave-me-alone individualism.
The End of Michael Flynn's Prosecution Was Another Triumph for America's Autocrat-in-Chief
Press coverage of the Flynn case shows that the media has failed yet again to grasp the larger narrative of Donald Trump's presidency.
With Tara Reade's Allegations, Joe Biden’s Campaign Is Only the Latest Chapter of America’s Accountability Problem
Biden has said, “I am not sorry for anything I have ever done."
The Perversity of Needing to See Ahmaud Arbery Die on Video to Recognize That His Black Life Mattered
It is its own grave affront that the circulation of intolerable scenes of brutality against black people remain necessary.
The "Coup" Attempt in Venezuela Seems Ridiculous. But Don't Forget — Regime Change Is the U.S. Goal.
Venezuela has faced enduring hostility from Washington due to its huge oil reserves and its opposition to U.S. policy and capitalism.
Four Die-Hard Loyalists Are Enabling Trump's Apocalyptic Coronavirus Response
Kushner, Miller, Pompeo, and Barr are using the nation’s greatest public health crisis in a century to foment hoaxes and punish the president's enemies.
Watch: Is China Merely a Competitor of the U.S., or an Adversary or Even an Enemy?
As hostile rhetoric toward Beijing increases, how should the U.S. view China?
With Patents on Coronavirus Medicines, International Drug Companies Will Decide Whether Brazilians Live or Die
U.S. and European drug companies will hold monopoly power over coronavirus medicines for years — straining health care systems of countries like Brazil.